Advertisement
Advertisement
U.S. markets open in 2 hours 2 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Paragon 28, Inc. (FNA)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
18.71+18.71 (+16.94%)
At close: 4:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close16.00
Open19.15
Bid18.35 x 800
Ask18.70 x 800
Day's Range17.52 - 19.92
52 Week Range17.52 - 19.92
Volume4,194,433
Avg. Volume4,346,100
Market Cap1.407B
Beta (5Y Monthly)N/A
PE Ratio (TTM)311.83
EPS (TTM)0.06
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for FNA

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • N/A
    Daily – Vickers Top Buyers & Sellers for 09/23/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    25 days agoArgus Research
View more
  • PR Newswire

    Paragon 28, Inc. Announces Pricing of Initial Public Offering

    Paragon 28, Inc. (NYSE: FNA) ("PARAGON"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced the pricing of its initial public offering of 7,812,500 shares of its common stock at a public offering price of $16.00 per share, for total gross proceeds of $125.0 million, before deducting underwriting discounts and commissions and estimated offering expenses. All of the shares are being offered and sold by PARAGON. PARAGON's common stock is e

Advertisement
Advertisement